Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-008421
Filing Date
2022-02-10
Accepted
2022-02-10 16:15:03
Documents
1
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 SUBMISSION doc5.html 5  
1 FORM 5 SUBMISSION doc5.xml 5 3460
  Complete submission text file 0001209191-22-008421.txt   4912
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Issuer) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ADAPTIMMUNE THERAPEUTICS PLC 60 JUBILEE AVE, MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address
Zaks Tal Zvi (Reporting) CIK: 0001690927 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-16174 | Film No.: 22614079